Guess which ASX healthcare stock is rocketing 5% today (hint: not ResMed!)

This stock is outpacing the broader sector today.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare stocks are shining today and staging a recovery from the past week's sell-off.

At the time of writing, the S&P/ASX Healthcare Index (ASX: XHJ) is up more than 1% against the benchmark S&P/ASX 200 Index (ASX: XJO)'s 0.5% gain.

Regis Healthcare Ltd (ASX: REG) is an ASX healthcare stock that is on a roll today, surging 5% to fetch $4.36 per share at the time of writing.

Despite no market-sensitive announcements from the company, the stock is one of the top-performing healthcare names at the time of publication on Wednesday, according to CommSec data.

With many focused on health darlings like ResMed Inc (ASX: RMD), you don't want to miss the forest for the trees. There are plenty more names in the healthcare sector.

Let's dive into this lesser-known ASX healthcare stock.

ASX healthcare stock catching a bid

Regis Healthcare is one of Australia's largest aged care providers. The stock is up more than 78% in the past twelve months.

In May, Macquarie analysts rated the ASX healthcare stock a buy. According to my colleague James, the broker cited favourable recommendations from the Aged Care Taskforce as its reasoning.

These recommendations are aimed at supporting a sustainable and innovative aged care system, which bodes well for Regis' future growth, Macquarie says.

The anticipated increase in earnings through 2028 from the industry changes led Macquarie to lift its earnings estimates and set a price target of $5.50 on the ASX healthcare stock.

Financials also a talking point

Regis Healthcare's latest financial results are another talking point, in my opinion. For the first half of FY24, the company reported:

  • Revenue of $480.1 million, up 26% year on year
  • Pre-tax earnings of $52.1 million, a 16% increase compared to the previous period
  • Net profit of $16.3 million, up a staggering 527% from the same period last year

These underlying figures paint a positive picture of growth and profitability.

Whilst it operates in aged care, the ASX healthcare stock's management is rejuvenating the company's balance sheet.

For instance, the company's recent acquisition of CPSM has added five more aged care homes to its books.

This brings its total to 68 residences with 7,604 beds under management. In my view, this expansion has been a significant driver behind the ASX healthcare stock's gain over the past 12 months.

Foolish takeaway

Regis Healthcare is catching a strong bid on Wednesday despite no company-specific news.

With healthcare stocks in general staging a recovery today, it's not unlikely that investors saw an opportunity to buy a high-quality franchise with solid H1 FY24 financials.

It could also be speculation. Who's to truly know?

Past performance is no guarantee of future results, though. As always, conduct your own due diligence and consider chatting to a professional.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Healthcare Shares

Is Sigma Healthcare share a healthy buy, after hitting new lows?

The Chemist Warehouse merger and ageing population might boost this stock's appeal.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares fall despite 'significant milestone'

Let's see what the biotech has announced on Monday.

Read more »

A male doctor wearing a white doctor's coat shrugs and holds his hands up to indicate the unimpressive CSL share price as a result of OOVID-19
Healthcare Shares

Here's the earnings forecast out to 2030 for CSL shares

How healthy will the profit growth be in the coming years?

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »